The vaccine is expected to be commercially ready for the 2025-2026 COVID-19 season. The Food and Drug Administration (FDA) has approved Nuvaxovid ™ (COVID-19 Vaccine, Adjuvanted) for active ...

The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines that target the Omicron KP.2 strain of SARS-CoV-2 which was dominant in the US in recent ...

The FDA has amended the emergency use authorisation (EUA) for Comirnaty in line with its experts' advice – for people aged over 65 and other adults at risk of getting severe COVID-19, either ...

McDonald’s says it's closing down CosMc’s, a new restaurant format it began piloting in the U.S. last year. But the company said on Friday that beverages inspired by CosMc’s will ...

The HHS blocked $11.4 billion in grants that are designed to counter public health threats including COVID-19, terminations Secretary ... as well as supporting flu and RSV vaccination education ...

New Study Traces Impact of COVID-19 Pandemic on Global Movement and Evolution of Seasonal Flu Nov. 7, 2024 — Increased capabilities for genomic surveillance have offered new insights into global ...

May 8, 2025 — Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows. The new molecule combines the specificity of a mature ...

Caroline Basile is Forbes Advisor’s student loans and mortgages deputy editor. With experience in both the mortgage industry and as a journalist, she was previously an editor with HousingWire ...

May 16, 2025 • New financial pressures on clinics that provide abortion are forcing some to close their doors, even in states that protect the right to abortion.

On a balance of £20,000, you would take home £744 from the bond, whereas you would take home £852 from the top one-year tax free ISA. If you are not a taxpayer or you are not yet fully using ...